{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:20:57Z","timestamp":1791163257824,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1177\/1933719107314063","type":"journal-article","created":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T22:13:21Z","timestamp":1211494401000},"page":"400-410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Loss of Cyclin G1 Expression in Human Uterine Leiomyoma Cells Induces Apoptosis"],"prefix":"10.1007","volume":"15","author":[{"given":"Sang-Hoon","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Cheol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabarish","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Do","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Young","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ku","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insoo","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Heum","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,31]]},"reference":[{"key":"15040400_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1289\/ehp.00108s5779","volume":"108","author":"SJ Robboy","year":"2000","unstructured":"Robboy SJ, Bentley RC, Butnor K., Anderson MC Pathology and pathophysiology of uterine smooth-muscle tumors. Environ Health Perspect. 2000;108:779\u2013784.","journal-title":"Environ Health Perspect"},{"key":"15040400_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","volume":"357","author":"EA Stewart","year":"2001","unstructured":"Stewart EA Uterine fibroids. Lancet. 2001;357:293\u2013298.","journal-title":"Lancet"},{"key":"15040400_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0015-0282(16)45789-4","volume":"36","author":"VC Buttram","year":"1981","unstructured":"Buttram VC, Reiter RC Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36:433\u2013445.","journal-title":"Fertil Steril"},{"key":"15040400_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/00003081-199712000-00029","volume":"40","author":"KJ Carlson","year":"1987","unstructured":"Carlson KJ Outcomes of hysterectomy. Clin Obstet Gynecol. 1987;40:939\u2013946.","journal-title":"Clin Obstet Gynecol"},{"key":"15040400_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/1098-2264(200007)28:3<235::AID-GCC1>3.0.CO;2-7","volume":"28","author":"AH Ligon","year":"2000","unstructured":"Ligon AH, Morton CC Genetics of uterine leiomyomata. Genes Chrom Cancer. 2000;28:235\u2013245.","journal-title":"Genes Chrom Cancer"},{"key":"15040400_CR6","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1067\/mob.2003.140","volume":"188","author":"WK Baek","year":"2003","unstructured":"Baek WK, Kim D., Jung N., et al. Increased expression of cyclin G1 in leiomyoma compared with normal myometrium. Am J Obstet Gynecol. 2003;188:634\u2013639.","journal-title":"Am J Obstet Gynecol"},{"key":"15040400_CR7","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1074\/jbc.271.11.6050","volume":"271","author":"MC Horne","year":"1996","unstructured":"Horne MC, Goolsby GL, Donaldson KL, et al. Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J Biol Chem. 1996;271:6050\u20136061.","journal-title":"J Biol Chem"},{"key":"15040400_CR8","first-page":"2113","volume":"8","author":"K Tamura","year":"1993","unstructured":"Tamura K., Kanaoka Y., Jinno S., et al. Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1. Oncogene. 1993;8:2113\u20132118.","journal-title":"Oncogene"},{"key":"15040400_CR9","doi-asserted-by":"publisher","first-page":"6593","DOI":"10.1128\/MCB.16.11.6593","volume":"16","author":"K Okamoto","year":"1996","unstructured":"Okamoto K., Kamibayashi C., Serrano M., Prives C., Mumby MC, Beach D. p53-dependent association between cyclin G and the B\u2032 subunit of protein phosphatase 2A. Mol Cell Biol. 1996;16:6593\u20136602.","journal-title":"Mol Cell Biol"},{"key":"15040400_CR10","first-page":"47","volume":"29","author":"MR Jackman","year":"1997","unstructured":"Jackman MR, Pines JN Cyclins and the G2\/M transition. Cancer Surv. 1997;29:47\u201373.","journal-title":"Cancer Surv"},{"key":"15040400_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0959-437X(97)80106-2","volume":"7","author":"RP Fisher","year":"1997","unstructured":"Fisher RP CDKs and cyclins in transition(s). Curr Opin Genet Dev. 1997;7:32\u201338.","journal-title":"Curr Opin Genet Dev"},{"key":"15040400_CR12","first-page":"1103","volume":"13","author":"S Bates","year":"1996","unstructured":"Bates S., Rowan S., Vousden KH Characterization of human cyclin G1 and G2: DNA damage inducible genes. Oncogene. 1996;13:1103\u20131109.","journal-title":"Oncogene"},{"key":"15040400_CR13","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1089\/hum.1997.8.14-1667","volume":"8","author":"DS Chen","year":"1997","unstructured":"Chen DS, Zhu NL, Hung G., et al. Retroviral vector-mediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice. Hum Gene Ther. 1997;8:1667\u20131674.","journal-title":"Hum Gene Ther"},{"key":"15040400_CR14","first-page":"5493","volume":"55","author":"M Skotzko","year":"1995","unstructured":"Skotzko M., Wu LT, Anderson WF, Gordon EM, Hall FL Retroviral vector-mediated gene-transfer of antisense cyclin G1 (CYCG1) inhibits proliferation of human osteogenic-sarcoma cells. Cancer Res. 1995;55:5493\u20135498.","journal-title":"Cancer Res"},{"key":"15040400_CR15","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1053\/jhep.2003.50137","volume":"37","author":"MR Jensen","year":"2003","unstructured":"Jensen MR, Factor VM, Fantozzi A., Helin K., Huh CG, Thorgeirsson SS Reduced hepatic tumor incidence in cyclin G1-deficient mice. Hepatology. 2003;37:862\u2013870.","journal-title":"Hepatology"},{"key":"15040400_CR16","doi-asserted-by":"publisher","first-page":"27449","DOI":"10.1074\/jbc.M111693200","volume":"277","author":"DA Bennin","year":"2002","unstructured":"Bennin DA, Don AS, Brake T., et al. Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B\u2032 subunits in active complexes and induces nuclear aberrations and a G1\/S phase cell cycle arrest. J Biol Chem. 2002;277:27449\u201327467.","journal-title":"J Biol Chem"},{"key":"15040400_CR17","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1002\/j.1460-2075.1994.tb06807.x","volume":"13","author":"K Okamoto","year":"1995","unstructured":"Okamoto K., Beach D. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J.1995;13:4816\u20134822.","journal-title":"EMBO J"},{"key":"15040400_CR18","first-page":"2361","volume":"10","author":"A Zauberman","year":"1995","unstructured":"Zauberman A., Lupo A., Oren M. Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites. Oncogene. 1995;10:2361\u20132366.","journal-title":"Oncogene"},{"key":"15040400_CR19","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1038\/sj.onc.1204270","volume":"20","author":"SH Kimura","year":"2001","unstructured":"Kimura SH, Ikawa M., Ito A., Okabe M., Nojima H. Cyclin G1 is involved in G2\/M arrest in response to DNA damage and in growth control after damage recovery. Oncogene. 2001;20: 3290\u20133300.","journal-title":"Oncogene"},{"key":"15040400_CR20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1097-2765(02)00504-X","volume":"9","author":"K Okamoto","year":"2002","unstructured":"Okamoto K., Li H., Jensen MR, et al. Cyclin G recruits PP2A to dephosphorylate Mdm2. Mol Cell. 2002;9:761\u2013771.","journal-title":"Mol Cell"},{"key":"15040400_CR21","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1038\/sj.onc.1206306","volume":"22","author":"T Ohtsuka","year":"2003","unstructured":"Ohtsuka T., Ryu H., Minamishima YA, Ryo A., Lee SW Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation. Oncogene. 2003;22:1678\u20131687.","journal-title":"Oncogene"},{"key":"15040400_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1023\/A:1006852613083","volume":"172","author":"WM Flanagan","year":"1997","unstructured":"Flanagan WM, Wagner RW Potent and selective gene inhibition using antisense oligodeoxynucleotides. Mol Cell Biochem. 1997;172:213\u2013225.","journal-title":"Mol Cell Biochem"},{"key":"15040400_CR23","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1126\/science.7684856","volume":"260","author":"RW Wagner","year":"1993","unstructured":"Wagner RW, Matteucci MD, Lewis JG, Gutierrez AJ, Moulds C., Froehler BC Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science. 1993;260:1510\u20131513.","journal-title":"Science"},{"key":"15040400_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1042\/bj3460295","volume":"346","author":"IJ Moon","year":"2000","unstructured":"Moon IJ, Lee Y., Kwak CS, et al. Target site search and effective inhibition of leukaemic cell growth by a covalently closed multiple anti-sense oligonucleotide to c-myb. Biochem J. 2000;346:295\u2013303.","journal-title":"Biochem J"},{"key":"15040400_CR25","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1074\/jbc.275.7.4647","volume":"275","author":"IJ Moon","year":"2000","unstructured":"Moon IJ, Choi K., Choi, YK et al. Potent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-myb1. J Biol Chem. 2000;275:4647\u20134653.","journal-title":"J Biol Chem"},{"key":"15040400_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/molehr\/gam071","volume":"13","author":"DH Nam","year":"2007","unstructured":"Nam DH, Ramachandran S., Song DK, et al. Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone. Mol Hum Reprod. 2007;13:829\u2013836.","journal-title":"Mol Hum Reprod"},{"key":"15040400_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/molehr\/gal018","volume":"12","author":"M Zaitseva","year":"2006","unstructured":"Zaitseva M., Vollenhoven BJ, Rogers PA In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells. Mol Hum Reprod. 2006;12:187\u2013207.","journal-title":"Mol Hum Reprod"},{"key":"15040400_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.tox.2005.10.013","volume":"218","author":"KY Kwon","year":"2006","unstructured":"Kwon KY, Jang JH, Choi WI, Ramachandran S., Cho CH, Cagle PT Expression of apoptotic nuclei by ultrastructural terminal deoxyribonucleotidyl transferase mediated dUTP nick end labeling and detection of FasL, caspases and PARP protein molecules in cadmium induced acute alveolar cell injury. Toxicology. 2006;218:197\u2013204.","journal-title":"Toxicology"},{"key":"15040400_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00001703-199306000-00003","volume":"5","author":"BS Verkauf","year":"1993","unstructured":"Verkauf BS Changing trends in treatment of leiomyomata uteri. Curr Opin Obstet Gynecol. 1993;5:301\u2013310.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"15040400_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07435807509053836","volume":"2","author":"A Corbin","year":"1975","unstructured":"Corbin A., Beattie CW Inhibition of the pre-ovulatory proestrous gonadotropin surge, ovulation, and pregnancy with a peptide analogue of luteinizing hormone releasing hormone. Endocr Res Commun. 1975;2:1\u201323.","journal-title":"Endocr Res Commun"},{"key":"15040400_CR31","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1210\/jcem-51-4-873","volume":"51","author":"D Rabin","year":"1980","unstructured":"Rabin D., McNeil LW Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females. J Clin Endocrinol Metab. 1980;51:873\u2013876.","journal-title":"J Clin Endocrinol Metab"},{"key":"15040400_CR32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1210\/jcem-67-4-701","volume":"67","author":"JS Johansen","year":"1988","unstructured":"Johansen JS, Riis BJ, Hassager C., Moen M., Jacobson J., Christiansen C. The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism. J Clin Endocrinol Metab. 1988;67:701\u2013706.","journal-title":"J Clin Endocrinol Metab"},{"key":"15040400_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0015-0282(16)60782-3","volume":"52","author":"MY Dawood","year":"1989","unstructured":"Dawood MY, Lewis V., Ramos J. Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol. Fertil Steril. 1989;52:21\u201326.","journal-title":"Fertil Steril"},{"key":"15040400_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0015-0282(16)60486-7","volume":"51","author":"AJ Friedman","year":"1989","unstructured":"Friedman AJ, Harrison-Atlas D., Barbieri RL, Benacerraf B., Gleason R., Schiff I. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata. Fertil Steril. 1989;51:251\u2013256.","journal-title":"Fertil Steril"},{"key":"15040400_CR35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/1078-0432.971.11.3","volume":"11","author":"M Suggitt","year":"2005","unstructured":"Suggitt M., Bibby MC 50 years of preclinical anticancer drug screening: empirical to target-driven approaches. Clin Cancer Res. 2005;11:971\u2013981.","journal-title":"Clin Cancer Res"},{"key":"15040400_CR36","doi-asserted-by":"publisher","first-page":"9087","DOI":"10.1038\/sj.onc.1207231","volume":"22","author":"NM Dean","year":"2003","unstructured":"Dean NM, Bennett CF Antisense oligonucleotide-based therapeutics for cancer. Oncogene. 2003;22:9087\u20139096.","journal-title":"Oncogene"},{"key":"15040400_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1006\/excr.1996.3402","volume":"230","author":"ML Smith","year":"1997","unstructured":"Smith ML, Kontny HU, Bortnick R., Fornace AJ Jr. The p53-regulated cyclin G gene promotes cell growth: p53 downstream effectors cyclin G and Gadd45 exert different effects on cisplatin chemosensitivity. Exp Cell Res. 1997;230:61\u201368.","journal-title":"Exp Cell Res"},{"key":"15040400_CR38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1006\/bbrc.1997.8004","volume":"242","author":"A Shimizu","year":"1998","unstructured":"Shimizu A., Nishida J., Ueoka Y., et al. Cyclin G contributes to G2\/M arrest of cells in response to DNA damage. Biochem Biophys Res Commun. 1998;242:529\u2013533.","journal-title":"Biochem Biophys Res Commun"},{"key":"15040400_CR39","doi-asserted-by":"publisher","first-page":"11022","DOI":"10.1074\/jbc.274.16.11022","volume":"274","author":"CL Reimer","year":"1999","unstructured":"Reimer CL, Borras AM, Kurdistani SK, et al. Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+\/+ cells. J Biol Chem. 1999;274:11022\u201311029.","journal-title":"J Biol Chem"},{"key":"15040400_CR40","first-page":"195","volume":"1","author":"L Zhao","year":"2003","unstructured":"Zhao L., Samuels T., Winckler S., et al. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Mol Cancer Res. 2003;1:195\u2013206.","journal-title":"Mol Cancer Res"},{"key":"15040400_CR41","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1038\/sj.onc.1204270","volume":"20","author":"SH Kimura","year":"2001","unstructured":"Kimura SH, Ikawa M., Ito A., Okabe M., Nojima H. Cyclin G1 is involved in G2\/M arrest in response to DNA damage and in growth control after damage recovery. Oncogene. 2001;20: 3290\u20133300.","journal-title":"Oncogene"},{"key":"15040400_CR42","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1053\/jhep.2003.50137","volume":"37","author":"MR Jensen","year":"2003","unstructured":"Jensen MR, Factor VM, Fantozzi A., Helin K., Huh CG, Thorgeirsson SS Reduced hepatic tumor incidence in cyclin G1-deficient mice. Hepatology. 2003;37:862\u2013870.","journal-title":"Hepatology"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719107314063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719107314063\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719107314063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719107314063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:07:58Z","timestamp":1656810478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719107314063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["15040400"],"URL":"https:\/\/doi.org\/10.1177\/1933719107314063","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"31 December 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}